RPRX 144 SEC Filing Analysis

Latest settled — T+5d

RPRX ▲ +3.12% at T+5d

NEUTRAL call ✓ call won +3.12% · α vs SPY +2.16% · entry $52.85 → $54.50

Next anchor: T+20d in 2d

Last close $54.86 (close Jun 8) · +3.80% from $52.85 entry

Entry anchored
May 14, 03:59 PM ET
via Databento tick

T+1d

-1.48%

call -1.48% · α -1.41%

$52.07

settled 26d ago

T+5d

+3.12%

call +3.12% · α +2.16%

$54.50

settled 20d ago

T+20d

—

call — · α —

—

in 2d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Gregory Norden, an officer of Royalty Pharma, filed a Form 144 on May 14, 2026, indicating intent to sell 3,045 shares of common stock with an approximate market value of $161,385. The shares were acquired via vesting of restricted stock units on May 13, 2026, and the sale is a routine, small-dollar transaction relative to the company's $30.7B market cap.

Actionable Insight

This is a routine insider sale of a small number of shares acquired through equity compensation. No material signal for the stock. Monitor for any larger insider sales or changes in insider sentiment in future filings.

Key Facts

Filer: Gregory Norden (officer of Royalty Pharma)
Proposed sale: 3,045 shares of common stock
Approximate value: $161,385 (based on filing date price)
Shares acquired via RSU vesting on May 13, 2026
Sale intended to be executed through Merrill Lynch
Transaction size is ~0.0005% of Royalty Pharma's $30.7B market cap

Financial Impact

Proceeds of approximately $161,385, representing a negligible fraction of market cap

dilution

Risk Factors

Insider selling could be perceived negatively if it precedes a negative catalyst, but the small size here makes that unlikely

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

88% bullish (16 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

Document	Accession Number
144 Filing (Primary)	0001964306-26-000240
Document: 0001964306-26-000240-index.html	0001964306-26-000240
Document: 0001964306-26-000240.txt	0001964306-26-000240

12 reports for RPRX

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for RPRX — sortable, filterable
	Type				Now
May 28, 2026 12d ago	Insider Cluster NEUTRAL ★ 4/10	$55.76 $55.87	▲ +0.20%	▲ +2.72%	$54.86 (−1.61%)
May 28, 2026 12d ago	8-K NEUTRAL ★ 4/10	$55.76 $54.97	▼ −1.42%	▼ −1.12%	$54.86 (−1.61%)
May 22, 2026 19d ago	Insider Cluster NEUTRAL ★ 2/10	$54.50 $55.18	▲ +1.25%	▼ −0.41%	$54.86 (+0.66%)
May 15, 2026 25d ago	Insider Cluster NEUTRAL ★ 3/10	$52.07 $53.86	▲ +3.44%	▲ +1.82%	$54.86 (+5.36%)
May 14, 2026 26d ago	144 NEUTRAL ★ 2/10	$52.85 $54.50	▲ +3.12%	▲ +2.16%	$54.86 (+3.80%)
May 6, 2026 4w ago	8-K BULLISH ★ 6/10	$50.72 $51.70	▲ +1.93%	▲ +0.80%	$54.86 (+8.16%)
Apr 17, 2026 7w ago	Press Release NEUTRAL ★ 3/10	$50.00 $49.38	▼ −1.24%	▼ −1.79%	$54.86 (+9.72%)
Apr 15, 2026 7w ago	Press Release NEUTRAL ★ 3/10	$48.48 $49.64	▲ +2.39%	▲ +1.41%	$54.86 (+13.16%)
Apr 10, 2026 8w ago	DEFA14A NEUTRAL ★ 2/10	$48.43 $49.30	▲ +1.80%	▼ −1.50%	$54.86 (+13.28%)
Mar 30, 2026 10w ago	Press Release NEUTRAL ★ 4/10	$46.37 $46.87	▲ +1.08%	▼ −3.22%	$54.86 (+18.31%)

US Market Status

Market Closed — Opens in 7h 17m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access